HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Belch, J. J. Articles by Hill, A. Search for Related Content PubMed PubMed Citation Articles by Belch, J. J. Articles by Hill, A. Agricola Articles by Belch, J. J. Articles by Hill, A.

Evening primrose oil and borage oil in rheumatologic conditions^1,2,3

¹ From the Department of Medicine, Ninewells Hospital and Medical School, Dundee, United Kingdom.

Diets rich in arachidonic acid (20:4n-6) lead to the formation of 2-series prostaglandins (PGs) and 4-series leukotrienes (LTs), with proinflammatory effects. Nonsteroidal antiinflammatory drugs are used in rheumatoid arthritis to inhibit cyclooxygenase (prostaglandin-endoperoxide synthase), thereby decreasing production of 2-series PGs. Lipoxygenase activity remains intact, however, allowing LT production (eg, synthesis of LTB₄, a potent inflammatory mediator) to continue. Altering the essential fatty acid (EFA) content of the diet can modify some of these effects. Ingestion of a diet rich in evening primrose oil elevates concentrations of dihomo--linolenic acid (DGLA; 20:3n-6), which results in the production of 1-series PGs, eg, PGE₁. DGLA itself cannot be converted to LTs but can form a 15-hydroxyl derivative that blocks the transformation of arachidonic acid to LTs. Increasing DGLA intake may allow DGLA to act as a competitive inhibitor of 2-series PGs and 4-series LTs and thus suppress inflammation. The results of in vitro and animal work evaluating EFAs in inflammatory situations are encouraging, which has stimulated clinical workers to evaluate these compounds in rheumatoid arthritis. Several well-controlled, randomized clinical studies have now been completed in which various EFAs were evaluated as treatments. The results of most of these studies suggest some clinical benefit to these treatments; these data are reviewed here.

Key Words: Essential fatty acids • evening primrose oil • borage oil • rheumatoid arthritis • Raynaud phenomenon • Sjögren syndrome • dihomo--linolenic acid

This article has been cited by other articles:

				B. Galarraga, M. Ho, H. M. Youssef, A. Hill, H. McMahon, C. Hall, S. Ogston, G. Nuki, and J. J. F. Belch Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis Rheumatology, May 1, 2008; 47(5): 665 - 669. [Abstract] [Full Text] [PDF]

				M. van Eijsden, G. Hornstra, M. F van der Wal, T. G. Vrijkotte, and G. J Bonsel Maternal n-3, n-6, and trans fatty acid profile early in pregnancy and term birth weight: a prospective cohort study Am. J. Clinical Nutrition, April 1, 2008; 87(4): 887 - 895. [Abstract] [Full Text] [PDF]

				S. R. Shaikh and M. Edidin Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1277 - 1289. [Abstract] [Full Text] [PDF]

				L. Schaeffer, H. Gohlke, M. Muller, I. M. Heid, L. J. Palmer, I. Kompauer, H. Demmelmair, T. Illig, B. Koletzko, and J. Heinrich Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids Hum. Mol. Genet., June 1, 2006; 15(11): 1745 - 1756. [Abstract] [Full Text] [PDF]

				S. N. Cheuvront The Zone Diet Phenomenon: A Closer Look at the Science behind the Claims J. Am. Coll. Nutr., February 1, 2003; 22(1): 9 - 17. [Abstract] [Full Text] [PDF]